OncoaccuPanel™ identifying mutations that may help determine diagnostics/prognosis/specific therapies for patients with solid tumors. It covers small nucleotide variants (SNVs), insertions/deletions (indels), copy-number variations (CNV), splice variants (SV), microsatellite instability (MSI) and tumor mutational burden (TMB).

Cancer:

Breast Cancer, Colon Cancer, Gastric Cancer, Lung Cancer, Solid Tumor

Gene:

BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), HER-2 (Human epidermal growth factor receptor 2), KRAS (KRAS proto-oncogene GTPase), MSI (Microsatellite instability), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS)

Method:

Next-Generation Sequencing (NGS)

Approvals

Date

Cancer

Gene

Biomarker

Drug

Approved by

05/04/2022

Gastric Cancer